{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:56:34Z","timestamp":1792148194970,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00423-013-1114-1","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T04:12:29Z","timestamp":1380773549000},"page":"1123-1128","source":"Crossref","is-referenced-by-count":15,"title":["Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation"],"prefix":"10.1007","volume":"398","author":[{"given":"Jan","family":"Pfeiffenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Koschny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Radeleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.","family":"Ganten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"issue":"9822","key":"1114_CR1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245\u20131255","journal-title":"Lancet"},{"issue":"6","key":"1114_CR2","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2005.03.033","volume":"128","author":"AS Befeler","year":"2012","unstructured":"Befeler AS, Hayashi PH, Di Bisceglie AM (2012) Liver transplantation for hepatocellular carcinoma. Gastroenterology 128(6):1752\u20131764","journal-title":"Gastroenterology"},{"issue":"11","key":"1114_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693\u2013699","journal-title":"N Engl J Med"},{"issue":"5","key":"1114_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.gcb.2009.02.036","volume":"33","author":"A Hollebecque","year":"2009","unstructured":"Hollebecque A, Decaens T, Boleslawski E et al (2009) Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroenterol Clin Biol 33(5):361\u2013369","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"1114_CR5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378\u2013390","journal-title":"N Engl J Med"},{"issue":"1","key":"1114_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia\u2013Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10(1):25\u201334","journal-title":"Lancet Oncol"},{"issue":"1","key":"1114_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jhep.2013.02.026","volume":"59","author":"C Sposito","year":"2013","unstructured":"Sposito C, Mariani L, Germini A et al (2013) Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case\u2013control study. J Hepatol 59(1):59\u201366","journal-title":"J Hepatol"},{"issue":"9","key":"1114_CR8","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.transproceed.2010.07.090","volume":"42","author":"J Signorell","year":"2010","unstructured":"Signorell J, Hunziker T, Martinelli M, Koestner SC, Mohacsi PJ (2010) Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. Transplant Proc 42(9):3871\u20133875","journal-title":"Transplant Proc"},{"issue":"5","key":"1114_CR9","doi-asserted-by":"crossref","first-page":"E541","DOI":"10.1111\/j.1399-0012.2011.01465.x","volume":"25","author":"K Hoffmann","year":"2011","unstructured":"Hoffmann K, Hinz U, Hillebrand N et al (2011) Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis. Clin Transplant 25(5):E541\u2013E551","journal-title":"Clin Transplant"},{"issue":"10","key":"1114_CR10","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/1097-0142(19911115)68:10<2095::AID-CNCR2820681002>3.0.CO;2-Y","volume":"68","author":"I Yokoyama","year":"1991","unstructured":"Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE (1991) Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68(10):2095\u20132100","journal-title":"Cancer"},{"issue":"5","key":"1114_CR11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00007890-200003150-00018","volume":"69","author":"PA Sheiner","year":"2000","unstructured":"Sheiner PA, Magliocca JF, Bodian CA et al (2000) Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 69(5):781\u2013789","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"1114_CR12","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/lt.22336","volume":"17","author":"G Germani","year":"2011","unstructured":"Germani G, Gurusamy K, Garcovich M et al (2011) Which matters most: number of tumors, size of the largest tumor, or total tumor volume? Liver Transpl 17(Suppl 2):S58\u2013S66","journal-title":"Liver Transpl"},{"issue":"3","key":"1114_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejso.2009.10.001","volume":"36","author":"A Kornberg","year":"2010","unstructured":"Kornberg A, Kupper B, Tannapfel A et al (2010) Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 36(3):275\u2013280","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1114_CR14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/030089161109700404","volume":"97","author":"TE Pfiffer","year":"2011","unstructured":"Pfiffer TE, Seehofer D, Nicolaou A et al (2011) Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era. Tumori 97(4):436\u2013441","journal-title":"Tumori"},{"issue":"8","key":"1114_CR15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jjco\/hyq055","volume":"40","author":"DH Yoon","year":"2010","unstructured":"Yoon DH, Ryoo BY, Ryu MH et al (2010) Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Jpn J Clin Oncol 40(8):768\u2013773","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"1114_CR16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.dld.2011.12.009","volume":"44","author":"A Weinmann","year":"2012","unstructured":"Weinmann A, Niederle IM, Koch S et al (2012) Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Dig Liver Dis 44(5):432\u2013437","journal-title":"Dig Liver Dis"},{"issue":"1\u20132","key":"1114_CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000319548","volume":"79","author":"R Kim","year":"2010","unstructured":"Kim R, El-Gazzaz G, Tan A et al (2010) Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation. Oncology 79(1\u20132):62\u201366","journal-title":"Oncology"},{"issue":"11","key":"1114_CR18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1432-2277.2012.01540.x","volume":"25","author":"K Staufer","year":"2012","unstructured":"Staufer K, Fischer L, Seegers B et al (2012) High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Transpl Int 25(11):1158\u20131164","journal-title":"Transpl Int"},{"issue":"3","key":"1114_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/joc.2010.22.3.205","volume":"22","author":"MW Welker","year":"2010","unstructured":"Welker MW, Lubomierski N, Gog C et al (2010) Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditions. J Chemother 22(3):205\u2013211","journal-title":"J Chemother"},{"issue":"6","key":"1114_CR20","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","volume":"135","author":"A Villanueva","year":"2008","unstructured":"Villanueva A, Chiang DY, Newell P et al (2008) Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 135(6):1972\u20131983, e1\u2013e11","journal-title":"Gastroenterology"},{"issue":"5","key":"1114_CR21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2010.01.025","volume":"52","author":"S Bhoori","year":"2010","unstructured":"Bhoori S, Toffanin S, Sposito C et al (2010) Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. J Hepatol 52(5):771\u2013775","journal-title":"J Hepatol"},{"issue":"4","key":"1114_CR22","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.23437","volume":"51","author":"C Toso","year":"2010","unstructured":"Toso C, Merani S, Bigam DL, Shapiro AM, Kneteman NM (2010) Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology 51(4):1237\u20131243","journal-title":"Hepatology"},{"issue":"6","key":"1114_CR23","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.transproceed.2008.05.005","volume":"40","author":"A Nocera","year":"2008","unstructured":"Nocera A, Andorno E, Tagliamacco A et al (2008) Sirolimus therapy in liver transplant patients: an initial experience at a single center. Transplant Proc 40(6):1950\u20131952","journal-title":"Transplant Proc"},{"issue":"4","key":"1114_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/apt.12185","volume":"37","author":"KV Menon","year":"2013","unstructured":"Menon KV, Hakeem AR, Heaton ND (2013) Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 37(4):411\u2013419","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-013-1114-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-013-1114-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-013-1114-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T17:06:53Z","timestamp":1564333613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-013-1114-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1114"],"URL":"https:\/\/doi.org\/10.1007\/s00423-013-1114-1","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}